Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2015

01.12.2015 | Short Research Report

An observational study of cutaneous adverse drug reactions in a teaching hospital

verfasst von: Deepti Chopra, Vibha Sharma, Rohan Kapoor, Shridhar Dwivedi

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Background Pharmacotherapy is often impeded by adverse drug reactions (ADRs). Among these ADRs cutaneous reactions are the major class being easily identified and reported. If not noted early it has potential to develop into serious lesions. Objective To evaluate the clinical patterns of various drug induced cutaneous reactions. Setting A Teaching hospital in India. Methods All suspected cutaneous reactions to systemic drugs which were submitted to the ADR monitoring centre during a 6-month period (March 2014–August 2014) were analysed. Causality relationship, severity assessment and preventability assessment was also done. Results Out of 134 cutaneous ADRs, 56 % occurred in females, majority of cases were found in the age group of 41–50 years. The most common type of ADR was maculopapular rash (46.3 %) and majorly implicated drug class was antibiotics (51.3 %). Most (72.3 %) were mild. Polypharmacy and multiple comorbid conditions were important predisposing factors. Over half of the cases (58 %) were not preventable. Conclusion Cutaneous adverse reaction patterns and their causes vary as the result of changing use of drugs. In India, antibiotics are responsible for the majority of the cutaneous adverse drug reactions, and maculopapular rash is the side effect that is most reported.
Literatur
1.
Zurück zum Zitat Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.CrossRefPubMed Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.CrossRefPubMed
2.
Zurück zum Zitat Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229–32.PubMed Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229–32.PubMed
3.
Zurück zum Zitat Liao PJ, Shih CP, Mao CT, Deng ST, Hsieh MC, Hsu KH. The cutaneous adverse drug reactions: risk factors, prognosis and economic impacts. Int J Clin Pract. 2013;67:576–84.CrossRefPubMed Liao PJ, Shih CP, Mao CT, Deng ST, Hsieh MC, Hsu KH. The cutaneous adverse drug reactions: risk factors, prognosis and economic impacts. Int J Clin Pract. 2013;67:576–84.CrossRefPubMed
4.
Zurück zum Zitat Babu KS, Belgi G. Management of cutaneous drug reactions. Curr Allergy Asthma Rep. 2002;2:26–33.CrossRefPubMed Babu KS, Belgi G. Management of cutaneous drug reactions. Curr Allergy Asthma Rep. 2002;2:26–33.CrossRefPubMed
5.
Zurück zum Zitat Sharma VK, Sethuraman G. Adverse cutaneous reactions to drugs: an overview. J Postgrad Med. 1996;42:15–22.PubMed Sharma VK, Sethuraman G. Adverse cutaneous reactions to drugs: an overview. J Postgrad Med. 1996;42:15–22.PubMed
6.
Zurück zum Zitat Chatterjee S, Ghosh AP, Barbhuiya J, Dey SK. Adverse cutaneous drug reaction: a one year survey at a dermatology outpatient clinical of a tertiary care hospital. Indian J Pharmacol. 2006;38:429–31.CrossRef Chatterjee S, Ghosh AP, Barbhuiya J, Dey SK. Adverse cutaneous drug reaction: a one year survey at a dermatology outpatient clinical of a tertiary care hospital. Indian J Pharmacol. 2006;38:429–31.CrossRef
7.
Zurück zum Zitat Ding WY, Lee CK, Choon SE. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2010;49:834–41.CrossRefPubMed Ding WY, Lee CK, Choon SE. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2010;49:834–41.CrossRefPubMed
8.
Zurück zum Zitat Nandha R, Gupta A, Hashmi A. Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective. Int J Appl Basic Med Res. 2011;1:50–3.PubMedCentralCrossRefPubMed Nandha R, Gupta A, Hashmi A. Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective. Int J Appl Basic Med Res. 2011;1:50–3.PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Hiware S, Shrivastava M, Mishra D, Mukhi J, Puppalwar G. Evaluation of cutaneous drug reactions in patients visiting out patient departments of Indira Gandhi Government Medical College and Hospital (IGGMC and H), Nagpur. Indian J Dermatol. 2013;58:18–21.PubMedCentralCrossRefPubMed Hiware S, Shrivastava M, Mishra D, Mukhi J, Puppalwar G. Evaluation of cutaneous drug reactions in patients visiting out patient departments of Indira Gandhi Government Medical College and Hospital (IGGMC and H), Nagpur. Indian J Dermatol. 2013;58:18–21.PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008;102:408–11.CrossRefPubMed Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008;102:408–11.CrossRefPubMed
Metadaten
Titel
An observational study of cutaneous adverse drug reactions in a teaching hospital
verfasst von
Deepti Chopra
Vibha Sharma
Rohan Kapoor
Shridhar Dwivedi
Publikationsdatum
01.12.2015
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2015
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0161-9

Weitere Artikel der Ausgabe 6/2015

International Journal of Clinical Pharmacy 6/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.